✦ LIBER ✦

Harmonization of clinical trial guidelines for assessing the risk of inhibitor development in hemophilia A treatment

✍ Scribed by L. M. ALEDORT

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical and laboratory assessment of ca

✍ Peter O. Kwiterovich 📂 Article 📅 2008 🏛 Elsevier 🌐 English ⚖ 882 KB

Harmonization of clinical practice guide

✍ J. -Y. L. Reginster 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 809 KB

CDK inhibitors in clinical development f

✍ Fischer, Peter M; Gianella-Borradori, Athos 📂 Article 📅 2003 🏛 Informa plc 🌐 English ⚖ 450 KB

Risk axis: Implementation of structured

✍ Shailesh Kumar; Raksha Lutchman; Alistair W. Stewart; Vanessa M. Burrett; Breann 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB

Treatment characteristics and the risk o

✍ S. C. GOUW; H. M. VAN DEN BERG; S. LE CESSIE; J. G. VAN DER BOM 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 503 KB

Searching for the role of primary prophy

✍ A. COPPOLA; A. TAGLIAFERRI; M. FRANCHINI 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB